EUVIMEDEUVIMED entdecken
Open Access

Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus

Shady Younis iD, Salvinaz I Moutusy iD, Sajede Rasouli iD, Shaghayegh Jahanbani iD, Mahesh Pandit iD, Xiaohao Wu, Suman Acharya, Orr Sharpe iD, Tilini U Wijeratne iD, Marlayna L Harris, Emily Y Yang iD, Yashaar Chaichian iD und 12 weitere

Science Translational Medicine · 12.11.2025 · 17 (824)

DOI: 10.1126/scitranslmed.ady0210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 12.11.2025. Verfasst von Shady Younis und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Rheumatology, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: B-Lymphocytes, Lupus Erythematosus, Systemic, Herpesvirus 4, Human, Antigen-Presenting Cells. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by antinuclear antibodies (ANAs). Epstein-Barr virus (EBV) infection has been epidemiologically associated with SLE, yet its role in pathogenesis remains incompletely defined. Here, we developed an EBV-specific single-cell RNA-sequencing platform and used it to demonstrate that EBV infection reprograms autoreactive antinuclear antigen B cells to drive autoimmunity in SLE. We demonstrated that, in SLE, EBV + B cells are predominantly CD27 + CD21 low memory B cells that are present at increased frequencies and express ZEB2 , TBX21 (T-bet), and antigen-presenting cell transcriptional pathways. Integrative analysis of chromatin immunoprecipitation sequencing (ChIP-seq), assay for transposase-accessible chromatin sequencing (ATAC-seq), and RNA polymerase II occupancy data revealed EBV nuclear antigen 2 (EBNA2) binding at the transcriptional start sites and regulatory regions of CD27 , ZEB2 , and TBX21 , as well as the antigen-presenting cell genes demonstrated to be up-regulated in SLE EBV + B cells. We expressed recombinant antibodies from SLE EBV + B cells and demonstrated that they bind prototypical SLE nuclear autoantigens, whereas those from healthy individuals do not. We further found that SLE EBV + B cells can serve as antigen-presenting cells to drive activation of T peripheral helper cells with concomitant activation of related EBV − antinuclear double-negative 2 B cells and plasmablasts. Our results provide a mechanistic basis for EBV being a driver of SLE through infecting and reprogramming nuclear antigen-reactive B cells to become activated antigen-presenting cells with the potential to promote systemic disease–driving autoimmune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesLupus Erythematosus, SystemicHerpesvirus 4, HumanAntigen-Presenting CellsCellular ReprogrammingHumansT-Box Domain ProteinsSingle-Cell AnalysisEpstein-Barr Virus InfectionsAutoimmunityFemaleEpstein-Barr Virus Nuclear AntigensZinc Finger E-box Binding Homeobox 2

Substanzen

T-Box Domain ProteinsEpstein-Barr Virus Nuclear AntigensZinc Finger E-box Binding Homeobox 2

Autor:innen und Institutionen

  • Division of Immunology and Rheumatology, Stanford University, Stanford, CA 94305, USA.
  • VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
  • Research Service, US Department of Veterans Affairs Medical Center, Cincinnati, OH 45220, USA.
  • Cincinnati Education and Research for Veterans Foundation, Cincinnati, OH 45220, USA.
  • Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA 94305, USA.
  • Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Shady Younis, Salvinaz I Moutusy, Sajede Rasouli, Shaghayegh Jahanbani, Mahesh Pandit, Orr Sharpe, Tilini U Wijeratne, Emily Y Yang, Yashaar Chaichian, Matthew C Baker, Lawrence Steinman, Ann Marshak-Rothstein, Judith A James, Olivia M Martinez, Paul J Utz, Dana E Orange, Tobias V Lanz, William H Robinson

Förderung

  • BLRD VA
  • NIAID NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Younis, S., Moutusy, S. I., Rasouli, S., Jahanbani, S., Pandit, M., Wu, X., Acharya, S., Sharpe, O., Wijeratne, T. U., Harris, M. L., Yang, E. Y., Chaichian, Y., Parsafar, S., Baker, M. C., Harley, J. B., Meffre, E., Steinman, L., Marshak-Rothstein, A., James, J. A., …, & Robinson, W. H. (2025). Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Science Translational Medicine, 17(824). https://doi.org/10.1126/scitranslmed.ady0210

Vancouver

Younis S, Moutusy SI, Rasouli S, Jahanbani S, Pandit M, Wu X, et al. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Science Translational Medicine. 2025;17(824). doi:10.1126/scitranslmed.ady0210

BibTeX
@article{Younis2025,
  author = {Younis, Shady and Moutusy, Salvinaz I and Rasouli, Sajede and Jahanbani, Shaghayegh and Pandit, Mahesh and Wu, Xiaohao and Acharya, Suman and Sharpe, Orr and Wijeratne, Tilini U and Harris, Marlayna L and Yang, Emily Y and Chaichian, Yashaar and Parsafar, Shima and Baker, Matthew C and Harley, John B and Meffre, Eric and Steinman, Lawrence and Marshak-Rothstein, Ann and James, Judith A and Martinez, Olivia M and Utz, Paul J and Orange, Dana E and Lanz, Tobias V and Robinson, William H},
  title = {Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {824},
  doi = {10.1126/scitranslmed.ady0210}
}
Kostenlos starten →